New consumer health company Kenvue explodes

Johnson & Johnson spin-off shares rocket 22% on stock exchange debut First GSK spun-off its consumer operation into Haleon, now Johnson & Johnson (J&J) has done the same with its consumer health division, now dubbed Kenvue, to resounding approval on the New York Stock Exchange (NYSE). The decision to spin-off the division, first announced in September 2021,